Paolo is a passionate entrepreneur who has over 19 years of experience in the Life Sciences industry. He is involved as a scientific advisor in multiple technology innovation start-ups and is a member of leading industry associations.
Paolo’s goal as CEO of PMH is to continue investing in new technologies such as Artificial Intelligence, Machine Learning, Internet of Things and digital health. He is committed to contributing to the transformation of clinical trials through technology to support the delivery of treatments to patients faster, safer, and more cost-effective.